Close Menu

NEW YORK – The US Food and Drug Administration on Monday issued new guidance for SARS-CoV-2 test developers to evaluate the potential impact of viral mutations on the tests.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.